Keyword Analysis & Research: uptodate duloxetine
Keyword Research: People who searched uptodate duloxetine also searched
Search Results related to uptodate duloxetine on Search Engine
-
Serotonin-norepinephrine reuptake inhibitors: Pharmacology ... - UpToDate
https://www.uptodate.com/contents/serotonin-norepinephrine-reuptake-inhibitors-pharmacology-administration-and-side-effects
WebDec 5, 2023 · Serotonin-norepinephrine reuptake inhibitors (SNRIs) act primarily upon serotonergic and noradrenergic neurons, but have little or no effect upon cholinergic or histaminergic receptors [ 1 ]. SNRIs include: Desvenlafaxine. …
DA: 92 PA: 50 MOZ Rank: 34
-
General drug information - UpToDate
https://www.uptodate.com/contents/table-of-contents/drug-information/general-drug-information
WebLicensed to: UpToDate Marketing Professional Support Tag : [0602 - 104.224.13.121 - BB27E9F598 - PR14 - UPT - 20240327-23:12:13UTC] - SM - MD - LG - XL Loading
DA: 29 PA: 97 MOZ Rank: 7
-
Pharmacologic management of chronic non-cancer pain in adults - UpToDate
https://www.uptodate.com/contents/pharmacologic-management-of-chronic-non-cancer-pain-in-adults
WebMar 13, 2024 · Duloxetine — Of all antidepressants, duloxetine has the largest evidence base to support analgesic efficacy, and is effective and FDA approved for the treatment of painful diabetic neuropathy, fibromyalgia, chronic low back pain, and osteoarthritis . In addition to these indications, duloxetine is approved by the FDA for treatment of major ...
DA: 10 PA: 74 MOZ Rank: 73
-
Atypical antidepressants: Pharmacology, administration, and ... - UpToDate
https://www.uptodate.com/contents/atypical-antidepressants-pharmacology-administration-and-side-effects
WebMar 21, 2023 · Atypical antidepressants are frequently used in patients with major depression who have inadequate responses or intolerable side effects during first-line treatment with SSRIs [ 2 ]. However, atypical antidepressants are often first-line treatment if the drug has a desirable characteristic (eg, sexual side effects and weight gain occur less ...
DA: 49 PA: 3 MOZ Rank: 19
-
UpToDate
https://sso.uptodate.com/contents/duloxetine-patient-drug-information
Web{{configCtrl2.metaDescription()}}
DA: 85 PA: 46 MOZ Rank: 9
-
Switching antidepressant medications in adults - UpToDate
https://www.uptodate.com/contents/switching-antidepressant-medications-in-adults
WebDec 4, 2023 · A study of an administrative claims database found that among patients (n >130,000) who started antidepressant monotherapy for a new episode of depression, switching occurred in 9 percent [ 1 ]. This topic discusses switching from one antidepressant drug to another. Discontinuing antidepressants without switching to another drug and …
DA: 44 PA: 74 MOZ Rank: 51
-
Pharmacology antidepressants - UpToDate
https://www.uptodate.com/contents/image?imageKey=PC/53818
WebDuloxetine: 30 to 60: 60: ... UpToDate contributors initiate treatment at one-half or less of the usual starting dose shown and titrate more gradually; refer to clinical topic on management of panic disorder. Δ Maximum recommended dose of citalopram is 20 mg for patients >60 years of age, with significant hepatic insufficiency, or taking ...
DA: 100 PA: 97 MOZ Rank: 2
-
Duloxetine - StatPearls - NCBI Bookshelf
https://www.ncbi.nlm.nih.gov/books/NBK549806/
WebMay 29, 2023 · Duloxetine is a medication used to manage major depressive disorder (MDD), generalized anxiety disorder (GAD), fibromyalgia, diabetic peripheral neuropathy, and chronic musculoskeletal pain. Off-label uses for duloxetine include chemotherapy-induced peripheral neuropathy and stress urinary incontinence.
DA: 99 PA: 81 MOZ Rank: 34
-
Discontinuing antidepressant medications in adults - UpToDate
https://www.uptodate.com/contents/discontinuing-antidepressant-medications-in-adults
WebOct 21, 2022 · Patients who stop their antidepressants are at risk for the antidepressant discontinuation syndrome, especially if they abruptly stop the drug, taper it too quickly, or switch to a new antidepressant with a different pharmacodynamic profile [ 1-5 ]. Although discontinuation symptoms are generally mild and self-limiting, in some cases they are ...
DA: 77 PA: 41 MOZ Rank: 22
-
A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644852/
WebOct 23, 2020 · This systematic review confirms that the dual mechanism of duloxetine benefits the treatment of comorbid clinical conditions, and supports the efficacy, safety, and tolerability of duloxetine in short- and long-term treatments.
DA: 28 PA: 85 MOZ Rank: 7
